The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma

Ege University

Status: Completed

Conditions: Pancreas Cancer; Pancreatic Neoplasms

Study type: Observational

Funder types: Other

Identifiers

NCT06553040

EUTFHALPSCOREFORPANCREAS

Details and patient eligibility

About

The aim of this study is to investigate whether the albumin value and the ratios of biochemical markers; hemoglobin, albumin, lymphocyte and platelet (HALP score) and lymphocyte-C-reactive protein ratio (LCR) can predict the survival and recurrence of the disease in patients with pancreatic adenocarcinoma.

Enrollment: 87 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Whipple operation and total pancreatectomy due to pathologically confirmed pancreatic adenocarcinoma

Exclusion criteria

• Patients with other malignant tumors (choledochal tumor, papilla tumor and duodenal tumor)